Literature DB >> 31901075

A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade.

Christopher E Rudd1.   

Abstract

PD-1 mediates antitumor immunity by regulating lineage fate commitment and function of myeloid cells (see related Research Article by Strauss et al..).
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31901075     DOI： 10.1126/sciimmunol.aaz8128

Source DB:  PubMed          Journal:  Sci Immunol        ISSN： 2470-9468


  8 in total

1.  Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database.

Authors:  Binghui Liu; Lingbin Chen; He Huang; Huifeng Huang; Hui Jin; Chenglin Fu
Journal:  Dis Markers       Date:  2022-06-16       Impact factor: 3.464

Review 2.  Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy.

Authors:  Gaia Giannone; Eleonora Ghisoni; Sofia Genta; Giulia Scotto; Valentina Tuninetti; Margherita Turinetto; Giorgio Valabrega
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

Review 3.  Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.

Authors:  Stephen P Hack; Andrew X Zhu; Yulei Wang
Journal:  Front Immunol       Date:  2020-11-05       Impact factor: 7.561

Review 4.  Rethinking immune checkpoint blockade: 'Beyond the T cell'.

Authors:  Xiuting Liu; Graham D Hogg; David G DeNardo
Journal:  J Immunother Cancer       Date:  2021-01       Impact factor: 13.751

5.  Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways.

Authors:  Ivones Hernández-Balmaseda; Idania Rodeiro Guerra; Ken Declerck; José Alfredo Herrera Isidrón; Claudina Pérez-Novo; Guy Van Camp; Olivier De Wever; Kethia González; Mayrel Labrada; Adriana Carr; Geovanni Dantas-Cassali; Diego Carlos Dos Reis; Livan Delgado-Roche; Roberto Rafael Nuñez; René Delgado-Hernández; Miguel David Fernández; Miriam T Paz-Lopes; Wim Vanden Berghe
Journal:  Mar Drugs       Date:  2021-01-22       Impact factor: 5.118

6.  Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification.

Authors:  Zhilei Qiu; Miao Xin; Chenyang Wang; Yueli Zhu; Qingnuan Kong; Zhijun Liu
Journal:  J Oncol       Date:  2022-02-15       Impact factor: 4.375

7.  Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer.

Authors:  Shuo Wu; Shipei Qiu; Wei Chen; Liucheng Ding; Lejun Wu
Journal:  Dis Markers       Date:  2022-10-10       Impact factor: 3.464

8.  Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

Authors:  Janna Krueger; Francois Santinon; Alexandra Kazanova; Mark E Issa; Bruno Larrivee; Richard Kremer; Catalin Milhalcioiu; Christopher E Rudd
Journal:  PLoS One       Date:  2021-06-28       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.